Rapamycin/IL-2 Combination Therapy in Patients With Type 1 Diabetes Augments Tregs yet Transiently Impairs β-Cell Function

Bibliographic Details
Main Authors: Long, S. Alice, Rieck, Mary, Sanda, Srinath, Bollyky, Jennifer B., Samuels, Peter L., Goland, Robin, Ahmann, Andrew, Rabinovitch, Alex, Aggarwal, Sudeepta, Phippard, Deborah, Turka, Laurence A., Ehlers, Mario R., Bianchine, Peter J., Boyle, Karen D., Adah, Steven A., Bluestone, Jeffrey A., Buckner, Jane H., Greenbaum, Carla J.
Format: Online
Language:English
Published: American Diabetes Association 2012
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3425404/
id pubmed-3425404
recordtype oai_dc
spelling pubmed-34254042013-09-01 Rapamycin/IL-2 Combination Therapy in Patients With Type 1 Diabetes Augments Tregs yet Transiently Impairs β-Cell Function Long, S. Alice Rieck, Mary Sanda, Srinath Bollyky, Jennifer B. Samuels, Peter L. Goland, Robin Ahmann, Andrew Rabinovitch, Alex Aggarwal, Sudeepta Phippard, Deborah Turka, Laurence A. Ehlers, Mario R. Bianchine, Peter J. Boyle, Karen D. Adah, Steven A. Bluestone, Jeffrey A. Buckner, Jane H. Greenbaum, Carla J. Immunology and Transplantation American Diabetes Association 2012-09 2012-08-17 /pmc/articles/PMC3425404/ /pubmed/22721971 http://dx.doi.org/10.2337/db12-0049 Text en © 2012 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.
repository_type Open Access Journal
institution_category Foreign Institution
institution US National Center for Biotechnology Information
building NCBI PubMed
collection Online Access
language English
format Online
author Long, S. Alice
Rieck, Mary
Sanda, Srinath
Bollyky, Jennifer B.
Samuels, Peter L.
Goland, Robin
Ahmann, Andrew
Rabinovitch, Alex
Aggarwal, Sudeepta
Phippard, Deborah
Turka, Laurence A.
Ehlers, Mario R.
Bianchine, Peter J.
Boyle, Karen D.
Adah, Steven A.
Bluestone, Jeffrey A.
Buckner, Jane H.
Greenbaum, Carla J.
spellingShingle Long, S. Alice
Rieck, Mary
Sanda, Srinath
Bollyky, Jennifer B.
Samuels, Peter L.
Goland, Robin
Ahmann, Andrew
Rabinovitch, Alex
Aggarwal, Sudeepta
Phippard, Deborah
Turka, Laurence A.
Ehlers, Mario R.
Bianchine, Peter J.
Boyle, Karen D.
Adah, Steven A.
Bluestone, Jeffrey A.
Buckner, Jane H.
Greenbaum, Carla J.
Rapamycin/IL-2 Combination Therapy in Patients With Type 1 Diabetes Augments Tregs yet Transiently Impairs β-Cell Function
author_facet Long, S. Alice
Rieck, Mary
Sanda, Srinath
Bollyky, Jennifer B.
Samuels, Peter L.
Goland, Robin
Ahmann, Andrew
Rabinovitch, Alex
Aggarwal, Sudeepta
Phippard, Deborah
Turka, Laurence A.
Ehlers, Mario R.
Bianchine, Peter J.
Boyle, Karen D.
Adah, Steven A.
Bluestone, Jeffrey A.
Buckner, Jane H.
Greenbaum, Carla J.
author_sort Long, S. Alice
title Rapamycin/IL-2 Combination Therapy in Patients With Type 1 Diabetes Augments Tregs yet Transiently Impairs β-Cell Function
title_short Rapamycin/IL-2 Combination Therapy in Patients With Type 1 Diabetes Augments Tregs yet Transiently Impairs β-Cell Function
title_full Rapamycin/IL-2 Combination Therapy in Patients With Type 1 Diabetes Augments Tregs yet Transiently Impairs β-Cell Function
title_fullStr Rapamycin/IL-2 Combination Therapy in Patients With Type 1 Diabetes Augments Tregs yet Transiently Impairs β-Cell Function
title_full_unstemmed Rapamycin/IL-2 Combination Therapy in Patients With Type 1 Diabetes Augments Tregs yet Transiently Impairs β-Cell Function
title_sort rapamycin/il-2 combination therapy in patients with type 1 diabetes augments tregs yet transiently impairs β-cell function
description
publisher American Diabetes Association
publishDate 2012
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3425404/
_version_ 1611551524092116992